+442,871.5%
NVDA vs EMR
+1,136.9%
+441,734.6%
-89.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.3% | -0.1% | -4.3% | -4.3% |
| 7D | -8.5% | +2.7% | -11.1% | -10.3% |
| 30D | -27.3% | +2.1% | -29.4% | -28.4% |
| 3M | -25.8% | +2.3% | -28.0% | -27.1% |
| 6M | -24.6% | +22.5% | -47.1% | -35.1% |
| YTD | -10.7% | +27.2% | -37.9% | -26.8% |
| 1Y | -14.0% | +28.0% | -42.1% | -30.0% |
| 3Y | +244.9% | +103.4% | +141.4% | +100.6% |
| 5Y | +449.3% | +88.2% | +361.1% | +240.9% |
| 10Y | +7,600.6% | +280.3% | +7,320.2% | +2,586.9% |
| All | +442,871.5% | +1,136.9% | +441,734.6% | +69,090.2% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling